SCHEMBL17769749

SCHEMBL17769749

CCC(=C(C(=O)O)C(=O)O)N(CC)c1ccc(F)c(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.43
ALDH1A1 P00352 2/20 0.43
CYP3A4 P08684 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
POLQ O75417 3/20 0.40
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TP53 P04637 1/20 0.38
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9084110 0.81 TSHR (0.42) TSHRALDH1A1CYP3A4SMN1; SMN2NPC1
SCHEMBL9302078 0.81 ALDH1A1 (0.48) TSHRALDH1A1CYP3A4SMN1; SMN2NPC1
SCHEMBL798178 0.76 TSHR (0.49) TSHRALDH1A1CYP3A4SMN1; SMN2NPC1
SCHEMBL2475462 0.73 ALDH1A1 (0.44) TSHRALDH1A1CYP3A4KMT2ATP53
SCHEMBL8622658 0.72 EPHX2 (0.36) TSHRALDH1A1SMN1; SMN2
SCHEMBL1904633 0.72 POLQ (0.50) TSHRALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL1429977 0.71 ALDH1A1 (0.44) TSHRALDH1A1SMN1; SMN2RAB9AKMT2A
SCHEMBL28807356 0.71 TERT (0.47) TSHRALDH1A1CYP3A4SMN1; SMN2NPC1
SCHEMBL2595067 0.71 ALDH1A1 (0.42) TSHRALDH1A1CYP3A4SMN1; SMN2KMT2A
SCHEMBL545097 0.71 TSHR (0.45) TSHRALDH1A1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3221295-A1 MONOCARBOXYLATE TRANSPORT MODULATORS AND USES THEREOF Nirogyone Therapeutics, Inc. (US) 2017-09-27 EP disclosed
WO-2016081464-A1 MONOCARBOXYLATE TRANSPORT MODULATORS AND USES THEREOF NIROGYONE THERAPEUTICS, INC. (US) 2016-05-26 WO disclosed